BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26191611)

  • 21. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
    Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment.
    Musholt TJ; Musholt PB; Petrich T; Oetting G; Knapp WH; Klempnauer J
    World J Surg; 2000 Nov; 24(11):1409-17. PubMed ID: 11038215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
    Mazeh H; Benavidez J; Poehls JL; Youngwirth L; Chen H; Sippel RS
    Thyroid; 2012 Jan; 22(1):3-8. PubMed ID: 22136209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial papillary thyroid microcarcinoma: a new clinical entity.
    Lupoli G; Vitale G; Caraglia M; Fittipaldi MR; Abbruzzese A; Tagliaferri P; Bianco AR
    Lancet; 1999 Feb; 353(9153):637-9. PubMed ID: 10030330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.
    Lupi C; Giannini R; Ugolini C; Proietti A; Berti P; Minuto M; Materazzi G; Elisei R; Santoro M; Miccoli P; Basolo F
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4085-90. PubMed ID: 17785355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases.
    Li Z; Zhang H; Yan Y; Li X; Jia M; Zhou H; Lu X
    Front Endocrinol (Lausanne); 2023; 14():1200855. PubMed ID: 37780622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
    Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
    Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
    Walczyk A; Kowalska A; Kowalik A; Sygut J; Wypiórkiewicz E; Chodurska R; Pięciak L; Góźdź S
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):899-904. PubMed ID: 24354346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial papillary thyroid carcinoma].
    Ji Q; Wu Y; Zhu Y; Wang Y; Zhang R; Luo Z
    Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):564-6. PubMed ID: 12417064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer.
    Rumyantsev PO; Saenko VA; Ilyin AA; Stepanenko VF; Rumyantseva UV; Abrosimov AY; Lushnikov EF; Rogounovitch TI; Shibata Y; Mitsutake N; Tsyb AF; Yamashita S
    J Clin Endocrinol Metab; 2011 Feb; 96(2):385-93. PubMed ID: 21084394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathologic characteristics of familial versus sporadic papillary thyroid carcinoma].
    Liang J; Li Z; Li S; Huang B; Liu H; Li Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jun; 50(6):502-6. PubMed ID: 26695804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma.
    de Carlos Artajo J; Irigaray Echarri A; García Torres J; Pineda Arribas JJ; Ernaga Lorea A; Eguílaz Esparza N; Zubiría Gortázar JM; Anda Apiñániz E
    Endocrinol Diabetes Nutr (Engl Ed); 2022 Apr; 69(4):262-270. PubMed ID: 35353680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.
    Bastos AU; Oler G; Nozima BH; Moysés RA; Cerutti JM
    Eur J Endocrinol; 2015 Oct; 173(4):525-40. PubMed ID: 26338373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases.
    Verburg FA; Mäder U; Luster M; Reiners C
    Eur J Endocrinol; 2009 Apr; 160(4):619-24. PubMed ID: 19158232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
    Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma.
    Kim TY; Kim WB; Rhee YS; Song JY; Kim JM; Gong G; Lee S; Kim SY; Kim SC; Hong SJ; Shong YK
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):364-8. PubMed ID: 16918957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
    Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Joshi V; Arnold A; Malchoff DM
    J Clin Endocrinol Metab; 2000 May; 85(5):1758-64. PubMed ID: 10843148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
    Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.